
Emma Walmsley earns £1M pay rise in her first full year at GSK's helm — but £5.9M package still trails other Big Pharma CEOs
Emma Walmsley’s £1 million ($1.3 million) pay raise in 2018 might have made her the highest-paid women on the FTSE 100, but the GlaxoSmithKline CEO’s compensation package still trails her peers in Big Pharma corner offices.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,600+ biopharma pros reading Endpoints daily — and it's free.